TherapeuticsMD (TXMD) Net Margin (2011 - 2026)

TherapeuticsMD (TXMD) posted Net Margin of 1.1% for Q1 2026, down 40.96% on a QoQ basis from 0.78% in Q4 2025, and up 322.0% year-over-year from 0.26% in Q1 2025.

TherapeuticsMD (TXMD) Net Margin (2011 - 2026) Analysis & Trends

TherapeuticsMD's Net Margin history runs 16 years deep, the most recent figure standing at 1.1% for Q1 2026.

  • Quarterly Net Margin rose 322.0% year-over-year to 1.1% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.77% (up 66.0% YoY) and the FY2025 annual result came in at 2.78%, down 466.0% from the prior year.
  • Net Margin was 1.1% for Q1 2026 at TherapeuticsMD, down from 0.78% in the prior quarter.
  • Across five years, Net Margin topped out at 36538.51% in Q2 2022 and bottomed at 4481.44% in Q1 2022.
  • A 5-year average of 1514.96% and a median of 0.94% in 2025 frame the typical range for Net Margin.
  • Peak annual rise in Net Margin reached 3672394 bps in 2022, while the deepest fall reached 428320 bps in 2022.
  • TherapeuticsMD's Net Margin stood at 42.66% in 2022, then soared by 229 bps to 140.3% in 2023, then slumped by 85 bps to 20.69% in 2024, then plunged by 104 bps to 0.78% in 2025, then sank by 41 bps to 1.1% in 2026.
  • Business Quant data shows TXMD's Net Margin at 1.1% in Q1 2026, 0.78% in Q4 2025, and 13.01% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 TherapeuticsMD 280,159.99 -8.14 Mn - -1.10%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.10%
Dec 31, 2025 -0.78%
Sep 30, 2025 13.01%
Jun 30, 2025 0.63%
Mar 31, 2025 -4.33%
Dec 31, 2024 20.69%
Sep 30, 2024 -7.68%
Jun 30, 2024 -17.09%
Mar 31, 2024 23.96%
Dec 31, 2023 140.30%
Sep 30, 2023 -3,667.92%
Mar 31, 2023 -310.82%
Dec 31, 2022 42.66%
Sep 30, 2022 -4,049.15%
Jun 30, 2022 36,538.51%
Mar 31, 2022 -4,481.44%
Dec 31, 2021 268.50%
Sep 30, 2021 -186.65%
Jun 30, 2021 -185.44%
Mar 31, 2021 -198.24%